Corcept Therapeutics Incorporated
CORT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,605,625 | $7,641,747 | $11,890,987 | $5,222,571 |
| - Cash | $125,138 | $102,745 | $89,819 | $127,665 |
| + Debt | $6,358 | $6,605 | $6,835 | $6,936 |
| Enterprise Value | $8,486,845 | $7,545,607 | $11,808,003 | $5,101,842 |
| Revenue | $207,638 | $194,430 | $157,214 | $181,890 |
| % Growth | 6.8% | 23.7% | -13.6% | – |
| Gross Profit | $203,042 | $190,997 | $154,811 | $178,934 |
| % Margin | 97.8% | 98.2% | 98.5% | 98.4% |
| EBITDA | $15,720 | $27,144 | $3,878 | $25,722 |
| % Margin | 7.6% | 14% | 2.5% | 14.1% |
| Net Income | $19,359 | $35,149 | $20,288 | $30,389 |
| % Margin | 9.3% | 18.1% | 12.9% | 16.7% |
| EPS Diluted | 0.16 | 0.29 | 0.17 | 0.26 |
| % Growth | -44.8% | 70.6% | -34.6% | – |
| Operating Cash Flow | $54,481 | $43,939 | $5,128 | $59,300 |
| Capital Expenditures | $0 | -$57 | -$104 | -$121 |
| Free Cash Flow | $54,481 | $43,882 | $5,024 | $59,179 |